CN1757739A - Method of expressing heparinase and its special expression carrier - Google Patents

Method of expressing heparinase and its special expression carrier Download PDF

Info

Publication number
CN1757739A
CN1757739A CN 200510090872 CN200510090872A CN1757739A CN 1757739 A CN1757739 A CN 1757739A CN 200510090872 CN200510090872 CN 200510090872 CN 200510090872 A CN200510090872 A CN 200510090872A CN 1757739 A CN1757739 A CN 1757739A
Authority
CN
China
Prior art keywords
heparinase
expression carrier
sequence
lys
green fluorescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510090872
Other languages
Chinese (zh)
Other versions
CN100355893C (en
Inventor
邢新会
陈银
况莹
叶逢春
罗明芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsinghua University
Original Assignee
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsinghua University filed Critical Tsinghua University
Priority to CNB2005100908722A priority Critical patent/CN100355893C/en
Publication of CN1757739A publication Critical patent/CN1757739A/en
Application granted granted Critical
Publication of CN100355893C publication Critical patent/CN100355893C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for expressing heparinase and its dedicated expression carrier are disclosed. Said heparinase expression carrier is a proerythroblast expression carrier for the coding gene of the fusion protein composed of heparinase and green fluorescin, and can be used for soluble expression and be correctly folded to prevent the generation of inclusion body. It can also be used to fast and quantitatively test the bacterial density and heparinase activity. Said method can realize the efficient soluble expression of said fusion protein (GFP-hepA).

Description

A kind of method and dedicated expression vector therefor thereof of expressing heparinase
Technical field
The present invention relates to a kind of method and dedicated expression vector therefor thereof of expressing heparinase.
Background technology
Heparinase (heparinase) is the polysaceharide lyase that a class acts on heparin, in many kinds of microorganisms, find, comprise excellent bacillus Corynebacterium sp. (high Ningguo etc., heparinase produces screening and the fermentation condition of bacterium, microorganism journal 1999 Vol.39:64-67), Sphingobacterium sp. Sphingobacterium sp. (high Ningguo etc., the generation of Sphingobacterium sp. heparinase, microorganism journal 2003 Vol.43:813-816), Bacillus subtillis Bacillus subtilis (Wang Zhongyan etc., heparinase produces the screening of bacterium and the research of thick enzymatic property thereof, Sichuan University's journal (natural science edition) 2002 Vol.39:777-779), Bacillus circulans Bacillus circulans (Yasutaka Tahara et al., Purification andcharacterization of heparinase that degrades both heparin and heparinsulfate from Bacillus circulans BioSci.Biotechnol.Biochem.2002Vol.66:1181-1184), Bacteroides heparinolyticus Prevotella heparinolytica (KazuyukiSugahara et al., Characterization of heparinase from an oral bacteriumPrevotella heparinolytica J.Biochem.1998 Vol.123:283-288), Bacteroides stercoris Bacteroides stercoris HJ-15 (Dong Hyuu Kim et al., Purification andcharacterization of a novel heparinase from Bacteroides stercoris HJ-15J.Biochem.2000 Vol.128:323-328) and heparin Flavobacterium Flavabacterium heparinum (Sasiekharan, R.1991 Ph.D.Thesis, Havard University).But the heparinase from the heparin Flavobacterium is business-like unique source.Heparinase from the heparin Flavobacterium mainly contains three kinds, difference called after Heparinase I (EC 4.2.2.7), II (NO EC code) and III (EC 4.2.2.8) (RobertJ.Linhardt et al., Purification and characterization of heparin lyasesfrom Flavobacterium heparinum JBC 1992 Vol.267:24347-24355).
Wherein the Heparinase I of heparin Flavobacterium (hepA) is one of heparinase of studying so far fullest, and the existing report of the application in the removal of its heparin in the production of Low molecular heparin and extracorporeal circulation of blood has the huge market development and is worth.Because the expression amount of heparin Flavobacterium product Heparinase I is low and purification process is loaded down with trivial details and expense is higher, thereby reorganization bacterium production Heparinase I receives great concern.
In the production technology optimization of Heparinase I, the rapid detection that the Heparinase I enzyme is lived is very important for the optimization of process.At present, the detection method that the Heparinase I enzyme is lived mainly contains two kinds, be respectively reddish black A method (Victor CY, Robert J L, et al.Purification and characterization of heparinase fromFlavobacterium heparinum.J.Biol.Chem.1985,260:1849-1857) and optical absorption method (the Ram S of 232nm, Bulmer M, et al.Cloning and expression of heparinase Igene from Flavobacterium heparinum.Proc.Natl.Acad.Sci.USA.1993,90:3660-3664).The measuring method of reddish black A is fit to crude enzyme liquid in these two kinds of methods, and is subjected to the influence of the polysaceharide lyase of other heparin of can degrading, and makes measuring result bigger than normal.And the 232nm optical absorption method is suitable for the measurement of the enzyme liquid of purifying.Because the kind of the unsaturated uronic acid that produces is many, ε=3800M -1Be mean value, so the measurement that enzyme is lived is very inaccurate yet.Detect enzymes from above-described two kinds and live the problems that exist as can be seen, in order to research and develop Heparinase I production technique efficiently, foundation can be quick and precisely quantitatively enzyme live efficiently express system and method is significant.
GFP, since (Chalfie M such as Chalfie in 1994, Tu Y, Euskirchen G, Ward WW, Prasher DC Green fluorescent protein as a marker for gene expression.Science 1994,263:802-805) in Bacillus coli cells, express first after, because this fluorescin is stable, pair cell nontoxicity, fluoroscopic examination are simple, and produce fluorescence and do not need characteristics such as substrate, become one of most widely used reporter protein in the research and development of physiology and biotechnology.But GFP mainly lays particular emphasis on various qualitative parsings at biology and Application in Biotechnology so far, and the Quantitative Monitoring and the process optimization that are applied to protein biological production process are new fields.(Poppenborg L such as Poppenborg, Friehs K, Flaschel E The green fluorescent protein is aversatile reporter for bioprocess monitoring.J.Biotechnol.1997 58:79-88) has proved first GFP has been fused to the fast monitored that can realize on the affine target thing such as processes such as cultivation, chromatographic separation.Therefore, GFP is the instrument with very big potentiality that is used for quantitative fast monitored cell cultures, optimizing fermentation and follows the trail of immobilized enzyme use characteristic.
Summary of the invention
The purpose of this invention is to provide a kind of heparanase expression carrier.
Heparanase expression carrier provided by the present invention is the procaryotic cell expression carrier that is inserted with the encoding gene of the fusion rotein that is made of heparinase and green fluorescent protein in multiple clone site.
The described procaryotic cell expression carrier that is inserted with the encoding gene of the fusion rotein that is made of heparinase and green fluorescent protein in multiple clone site can be at the expression in escherichia coli foreign gene.
Described intestinal bacteria can be bacillus coli DH 5 alpha, e. coli bl21 (DE3), e. coli jm109 or intestinal bacteria TB1 etc.
The described fusion rotein that is made of heparinase and green fluorescent protein is the gfp fragment that closely is connected with the 1-238 amino acids residue sequence that has sequence 1 in the sequence table at least at the aminoterminal of the amino acid residue sequence of heparinase or carboxyl terminal.
Described heparinase is a Heparinase I, and its amino acid residue sequence is numbered A47479 in the retrieval of GenBank.
The described fusion rotein that is made of heparinase and green fluorescent protein is the protein with one of following amino acid residue sequences:
1) the SEQ ID № in the sequence table: 2;
2) with SEQ ID № in the sequence table: 2 amino acid residue sequence is through the replacement of one or several amino-acid residue and/or disappearance and/or interpolation and have green fluorescent protein and the protein of heparanase activity.
Sequence 2 in the sequence table is made up of 626 amino-acid residues, is green fluorescent protein from the 1st of aminoterminal to the 238th amino acids residue, is Heparinase I from the 264th of aminoterminal to the 626th amino acids residue.
The replacement of described one or several amino-acid residue and/or disappearance and/or interpolation are meant replacement and/or disappearance and/or the interpolation that is no more than 10 amino-acid residues.
The encoding gene of the described fusion rotein that is made of heparinase and green fluorescent protein can have one of following nucleotide sequence:
1) SEQ ID № in the sequence table: 3 dna sequence dna;
2) SEQ ID № in the code sequence tabulation: the polynucleotide of 2 protein sequences;
3) under the rigorous condition of height can with SEQ ID № in the sequence table: the nucleotide sequence of the 3 dna sequence dnas hybridization that limit;
4) with sequence table in SEQ ID №: 3 dna sequence dnas that limit have 90% above homology, and the identical function protein DNA sequence of encoding.
The rigorous condition of described height can be 0.1 * SSPE (or 0.1 * SSC), in the solution of 0.1%SDS, under 65 ℃, hybridize and wash film.
Sequence 3 in the sequence table is by 1881 based compositions, and its encoding sequence is from the 1st to 1881 deoxynucleotide of 5 ' end.
Described heparanase expression carrier is preferably pGFP-hepA, and pGFP-hepA is that the encoding gene of the fusion rotein that will be made of heparinase and green fluorescent protein inserts the recombinant expression vector that obtains between NdeI in the multiple clone site of pMAL-c2x and HindIII recognition site.
Second purpose of the present invention provides a kind of method of expressing heparinase.
The method of expression heparinase provided by the present invention is that above-mentioned heparanase expression carrier is imported in the intestinal bacteria, and the bacterial strain that screening is obtained expressing heparinase is cultivated described engineering bacteria, the abduction delivering heparinase as engineering bacteria.
In this method, described intestinal bacteria are bacillus coli DH 5 alpha, e. coli bl21 (DE3), e. coli jm109 or intestinal bacteria TB1; Described heparanase expression carrier is preferably pGFP-hepA; Described abduction delivering condition in the substratum that contains 0.3-1mM IPTG 5-25 ℃ inducing culture 5-15 hour.
The present invention utilizes genetic engineering technique successfully to make up the efficient soluble-expression plasmid pGFP-hepA of GFP-Heparinase I fusion rotein, and the recombination bacillus coli that contains this plasmid can give expression to the GFP and the Heparinase I fusion rotein of solubility.Set up the method for utilizing GFP rapid detection e. coli concentration and Heparinase I enzyme to live by the mensuration that fluorescence intensity, cell concn and enzyme are lived, for the large-scale production optimization of Heparinase I provides new means.
The invention provides a kind of can folding with correct by soluble-expression, prevent that inclusion body from forming, and can fast quantification cell concentration and heparinase enzyme fusion expression vector (pGFP-hepA) alive.The method that the present invention expresses heparinase has realized the fusion rotein (GFP-hepA) that efficient soluble-expression is made of heparinase and green fluorescent protein, the expression amount of Heparinase I is up to the 350IU/L substratum, this expression method also can utilize fluorescence measurement that engineering bacteria concentration and the work of Heparinase I enzyme are carried out the fast quantification tracking, help the optimization and the control of Heparinase I production process, help the preservation of heparinase and the quick evaluation of application process, help resolving the structure and the mechanism of degradation of macromole heparin.Heparanase expression carrier of the present invention and expression method have wide prospect in industrial application and actual application value.
Description of drawings
Fig. 1 is the building process synoptic diagram of expression vector pMal-hepA
Fig. 2 is the Heparinase I gene electrophoretogram that pcr amplification obtains from the heparin Flavobacterium
Fig. 3 is the building process synoptic diagram of expression vector pGFP-hepA
Fig. 4 is the GFP-hepA fluorescent microscope photo of BL21 (DE3)/pGFP-hepA abduction delivering
Fig. 5 is the protein electrophorese collection of illustrative plates of BL21 (DE3)/pGFP-hepA different condition abduction delivering
Fig. 6 lives and OD for the fluorescence intensity of supernatant liquor after the cytoclasis, total enzyme 600Curve over time
Fig. 7 is relative intensity of fluorescence and OD 600Relation
Fig. 8 is the relation that relative intensity of fluorescence and Heparinase I enzyme are lived
Embodiment
Experimental technique among the following embodiment if no special instructions, is ordinary method.
The structure of embodiment 1, expression vector pGFP-hepA
1, the structure that contains the expression vector pMal-hepA of Heparinase I encoding gene
The building process of expression vector pMal-hepA as shown in Figure 1, detailed process is as follows: amplification Heparinase I gene from the genome DNA of heparin Flavobacterium Flavabacterium heparinum (buy from IAM), used upstream and downstream primer is respectively 5 ' GCCT GGATCCCAGCAAAAAAAATCCGGTAAC 3 ' (base of band underscore is the restriction enzyme site of BamHI), 5 ' GCTT CTGCAGTCTGGCAGTTTCGCTGTAC 3 ' (base of band underscore is the PstI restriction enzyme site), introduce BamHI and PstI restriction enzyme site respectively, 50 μ L amplification reaction systems are: the 50ng template DNA, every kind of primer of 100pmol, 1 * amplification buffer (sky, Beijing is a Bioisystech Co., Ltd), every kind of dNTP of 200 μ mol/L, the high Pfu enzyme of protecting of 1 unit; Amplification program is: 95 degrees centigrade of sex change 5 minutes, and 50-60 degree centigrade of primer annealing 45 seconds, 72 degrees centigrade of primer extensions 90 seconds, after 30 circulations, 72 degrees centigrade are extended and finished reaction in 5 minutes.This PCR result shows that amplification obtains the Heparinase I gene fragment of 1.1kb as shown in Figure 2.Among Fig. 2, it is 50,51,53,55,58 or 59 ℃ of amplifications that 1-6 is respectively the primer annealing temperature, and 7 is molecular weight marker 15kb, and arrow indication place is a 1.1kb target segment.
With pMal-p2x and pMal-c2x carrier (available from NEB company)) and the PCR product use BamHI and PstI double digestion respectively, use T 4Dna ligase connects, transform JM109, with 5 ' GCCTGGATCCCAGCAAAAAAAATCCGGTAAC 3 ' and 5 ' GCTTCTGCAGTCTGGCAGTTTCGCTGTAC 3 ' is primer, by bacterium colony PCR screening transformant, extraction can obtain plasmid in the transformant of 1.1kb PCR product by BamHI and the checking of PstI double digestion.To obtain the segmental plasmid of 1.1kb by BamHI and PstI double digestion and check order, will contain the plasmid called after pMal-hepA of nucleotide sequence with sequence 4 in the sequence table.
2, the structure of the expression vector pGFP-hepA of the encoding gene of the fusion rotein that constitutes by heparinase and green fluorescent protein
The building process of expression vector pGFP-hepA as shown in Figure 3, concrete grammar is as follows:
With plasmid pSG1729 (Bacillus Genetic Stock Center) is template, uses P Up: 5 ' AAAGGAGATTCGA CATATGGGTACCCTGCATATGAGTAAAGGA (NdeI) 3 ' (line part base is the recognition site of NdeI) and Pdo:5 ' CATCG GAGCTCGAGGTACCTTTGTATAGTTCATCCATGCCATGTG (SacI) 3 ' (line part base is the recognition site of SacI) is primer PCR amplification GFP gene (gfp), and be inserted between the enzyme recognition site NdeI and SacI of pMAL-c2x (available from NEB company), make up and obtained recombinant vectors pGFP-c2x.Utilize EcoRI and HindIII enzyme to cut pMal-hepA then, reclaim the hepA fragment of about 1100bp, and cut the big fragment of carrier that pGFP-c2x obtains through EcoRI and HindIII enzyme and be connected, will connect product transformed into escherichia coli DH5 α, blue hickie screening positive clone.Recombinant plasmid is cut through enzyme and is identified and confirm (worker is given birth in Shanghai) by sequencing, will contain the recombinant vectors called after pGFP-hepA of the encoding gene of the fusion rotein that is made of heparinase and green fluorescent protein with sequence 3 in the sequence table.
Embodiment 2, expression Heparinase I
1, abduction delivering
Extract the plasmid in the bacillus coli DH 5 alpha that contains pGFP-hepA among the embodiment 1,, screen and utilize primer P through penbritin according to ordinary method transformed into escherichia coli BL21 (DE3) UpAnd P DoCarry out bacterium colony PCR and identify, obtain containing the e. coli bl21 (DE3) of pGFP-hepA, promptly BL21 (DE3)/pGFP-hepA is as the engineering bacteria of expressing GFP-hepA.
BL21 (DE3)/pGFP-hepA was cultivated 2 hours for 37 ℃ at LB substratum (containing 100 μ g/ml penbritins), add 1mM IPTG and carry out inducing culture at 32 ℃, 20 ℃ and 15 ℃ respectively.Engineering bacteria BL21 (DE3)/pGFP-hepA inducing culture 8 hours, thalline is expressed the GFP-hepA fusion rotein, as shown in Figure 4.Get respectively and induce bacterium liquid 40ml behind the 12h, the centrifugal 10min of 10000rpm, with 20mmol/L Tris-HCl (pH 7.4) washed twice, be resuspended in and carry out ultrasonication among the 4ml 20mmol/L Tris-HCl (pH 7.4) (output rating is 300W, each ultrasonic 3 seconds and intermittently 3 seconds processing 99 times), get supernatant liquor 50 μ l and cytoclasis precipitation respectively and do full cell SDS-PAGE electrophoresis.The result shows that different inducing temperatures to the active obvious effect of GFP-hepA, induce at 32 ℃ as shown in Figure 5, and GFP-hepA exists more with the form of non-activity inclusion body, and 15 ℃ induced, and the amount of soluble g FP-hepA then obviously increases.Among Fig. 5, arrow shows GFP-hepA band, 70kDa; It is 32 ℃ of cytoclasis postprecipitations under the inducing temperature that 32 degree are induced insoluble; It is supernatant liquor after 32 ℃ of cytoclasises under the inducing temperature that 32 degree are induced solvable; It is 20 ℃ of cytoclasis postprecipitations under the inducing temperature that 20 degree are induced insoluble; It is supernatant liquor after 20 ℃ of cytoclasises under the inducing temperature that 20 degree are induced solvable; It is 15 ℃ of cytoclasis postprecipitations under the inducing temperature that 15 degree are induced insoluble; It is supernatant liquor after 15 ℃ of cytoclasises under the inducing temperature that 15 degree are induced solvable.
2, enzyme biopsy cls analysis
Measuring the enzyme of Heparinase I in accordance with the following methods lives: with cell centrifugation separate, with after Tris-HCl (pH7.0) washed twice, be resuspended among the 5ml Tris-HCl (pH7.0), carry out cytoclasis with the ultrasound condition of step 1.With broken liquid centrifugal after, the heparinase of surveying in the supernatant liquor is lived.The 232nm optical absorption method is adopted in the analysis that enzyme is lived, and the enzyme of an international unit (1IU) is lived and is defined as 30 ℃, and under pH 7.4 conditions, per minute produces the required protein content of 1 μ mol, 4,5 unsaturated uronic acids.
The result shows that BL21 (DE3)/pGFP-hepA cultivated 2 hours for 37 ℃ at LB substratum (containing 100 μ g/ml Amp), add 1mM IPTG and be respectively 0.0425IU, 0.105IU, 0.175IU 32 ℃, 20 ℃ and the 15 ℃ enzyme work of carrying out 12 hours cytoclasis supernatant liquor Heparinase I of inducing culture respectively, the expression amount of the Heparinase I that conversion obtains is respectively 85IU/L, 210IU/L, 350IU/L substratum.
Embodiment 3, fluorescent quantitation follow the trail of cell concentration and enzyme is lived
With the LB that contains 100 μ g/ml penbritins (NaCl 10g/L, tryptone 10g/L, yeast extract 5g/L, pH7.0) substratum is cultivated BL21 (DE3)/pGFP-hepA, 37 ℃ of cultivations about two hours (to OD 600Be 0.25) after, add 0.3mM IPTG, and change culture temperature into 15 ℃ and carry out inducing culture.Every 1 hour, get 1ml bacterium liquid and survey its cell concn (OD respectively 600), the enzyme of Heparinase I lives and fluorescence intensity (spectrophotofluorometer HITACHI F-2500), measure to inducing culture 14 hours always.
Measure the enzyme of Heparinase I according to the method for step 2 among the embodiment 2 and live, the result shows the prolongation of the enzyme work of Heparinase I along with induction time, and expression amount increases gradually.The mensuration of fluorescence intensity be according to the method for step 2 among the embodiment 2 with the cell centrifugation in this 1ml bacterium liquid separate, with after Tris damping fluid (pH7.0) washed twice, be resuspended in the 5ml Tris damping fluid (pH7.0), carry out cytoclasis with the ultrasound condition of step 1 among the embodiment 2.With broken liquid centrifugal after, survey the fluorescence intensity in the supernatant liquor, with inducing 0 hour fluorescence intensity to be decided to be 0, draw the relative intensity of fluorescence of other induction time.Cell concn (the OD of culturing process 600), the enzyme of Heparinase I is lived (IU/L substratum) and the variation of fluorescence intensity (RFU) as shown in Figure 6.Presentation of results, GFP albumen can improve the solubility of Heparinase I in intestinal bacteria, and along with the increase of induction time, fluorescence volume increases, but, need dilution or smudge cells with accurate measurement fluorescence volume (as Fig. 7, shown in Figure 8) owing to there is the scattering of cell.
Realize the quick online detection that cell concentration and enzyme are lived for further research and utilization GFP albumen, studied OD 600Relation with fluorescence intensity and enzyme work and fluorescence intensity.14 hours OD of above-mentioned 15 ℃ of inducing culture 600With the relation of fluorescence intensity as shown in Figure 7, show between bacterial concentration and the fluorescence to have good linear relationship, at lower OD 600In the scope, dilution or the result that do not dilute match influence not quite, but dependency and slope after the dilution obviously increase, and influence under high cell concentration condition the necessary consideration of cell to fluorescence scattering be described.Experimental result shows the fast quantification that can utilize fluorescence intensity to realize bacterial concentration in the culturing process.
Studied the relation between the work of fluorescence volume and enzyme simultaneously, the enzyme work of 14 hours Heparinase I of above-mentioned 15 ℃ of inducing culture and the relation of fluorescence intensity show that also there are good linear relationship in fluorescence volume and enzyme between living as shown in Figure 8.
The variation that The above results explanation can be lived with the enzyme of quick acquisition cell concentration and Heparinase I by fluorescence intensity in the fermentation culture process, thus realize the culturing process optimization and the control of High-efficient Production Heparinase I.
Sequence table
<160>4
<210>1
<211>238
<212>PRT
<213〉artificial sequence
<400>1
Met Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
1 5 10 15
Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val Ser Gly Val
20 25 30
Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser
35 40 45
Val Ser Gly Glu Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
50 55 60
Thr Tyr Gly Val Gln Cys Phe Ser Leu Pro Val Pro Trp Pro Thr Leu
65 70 75 80
Val Thr Thr Phe Ala Tyr Gly Leu Gln Cys Phe Glu Leu Pro Val Pro
85 90 95
Trp Pro Thr Leu Val Thr Thr Phe Ala Tyr Gly Leu Gln Cys Phe Glu
100 105 110
Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Phe Ala Tyr Gly Leu
115 120 125
Gln Cys Phe Glu Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Phe
130 135 140
Ala Tyr Gly Leu Gln Cys Phe Val Met Ala Asp Lys Pro Lys Asn Gly
145 150 155 160
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Ile Met Ala Asp Lys
165 170 175
Pro Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Ile
180 185 190
Met Ala Asp Lys Pro Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
195 200 205
His Asn Ile Asn Glu Lys Arg Asp His Met Ile Leu Leu Glu Phe Val
210 215 220
Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys
225 230 235
<210>2
<211>626
<212>PRT
<213〉artificial sequence
<220>
<223>
<400>2
Met Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
1 5 10 15
Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val Ser Gly Val
20 25 30
Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser
35 40 45
Val Ser Gly Glu Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
50 55 60
Thr Tyr Gly Val Gln Cys Phe Ser Leu Pro Val Pro Trp Pro Thr Leu
65 70 75 80
Val Thr Thr Phe Ala Tyr Gly Leu Gln Cys Phe Glu Leu Pro Val Pro
85 90 95
Trp Pro Thr Leu Val Thr Thr Phe Ala Tyr Gly Leu Gln Cys Phe Glu
100 105 110
Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Phe Ala Tyr Gly Leu
115 120 125
Gln Cys Phe Glu Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Phe
130 135 140
Ala Tyr Gly Leu Gln Cys Phe Val Met Ala Asp Lys Pro Lys Asn Gly
145 150 155 160
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Ile Met Ala Asp Lys
165 170 175
Pro Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Ile
180 185 190
Met Ala Asp Lys Pro Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
195 200 205
His Asn Ile Asn Glu Lys Arg Asp His Met Ile Leu Leu Glu Phe Val
210 215 220
Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys Gly Thr
225 230 235 240
Ser Ser Ser Asn Asn Asn Asn Asn Asn Asn Asn Asn Asn Leu Gly Ile
245 250 255
Glu Gly Arg Ile Ser Glu Phe Gln Gln Lys Lys Ser Gly Asn Ile Pro
260 265 270
Tyr Arg Val Asn Val Gln Ala Asp Ser Ala Lys Gln Lys Ala Ile Ile
275 280 285
Asp Asn Lys Trp Val Ala Val Gly Ile Asn Lys Pro Tyr Ala Leu Gln
290 295 300
Tyr Asp Asp Lys Leu Arg Phe Asn Gly Lys Pro Ser Tyr Arg Phe Glu
305 310 315 320
Leu Lys Ala Glu Asp Asn Ser Leu Glu Gly Tyr Ala Ala Gly Glu Thr
325 330 335
Lys Gly Arg Thr Glu Leu Ser Tyr Ser Tyr Ala Thr Thr Asn Asp Phe
340 345 350
Lys Lys Phe Pro Pro Ser Val Tyr Gln Asn Ala Gln Lys Leu Lys Thr
355 360 365
Val Tyr His Tyr Gly Lys Gly Ile Cys Glu Gln Gly Ser Ser Arg Ser
370 375 380
Tyr Thr Phe Ser Val Tyr Ile Pro Ser Ser Phe Pro Asp Asn Ala Thr
385 390 395 400
Thr Ile Phe Ala Gln Trp His Gly Ala Pro Ser Arg Thr Leu Val Ala
405 4l0 4l5
Thr Pro Glu Gly Glu Ile Lys Thr Leu Ser Ile Glu Glu Phe Leu Ala
420 425 430
Leu Tyr Asp Arg Met Ile Phe Lys Lys Asn Ile Ala His Asp Lys Val
435 440 445
Glu Lys Lys Asp Lys Asp Gly Lys Ile Thr Tyr Val Ala Gly Lys Pro
450 455 460
Asn Gly Trp Lys Val Glu Gln Gly Gly Tyr Pro Thr Leu Ala Phe Gly
465 470 475 480
Phe Ser Lys Gly Tyr Phe Tyr Ile Lys Ala Asn Ser Asp Arg Gln Trp
485 490 495
Leu Thr Asp Lys Ala Asp Arg Asn Asn Ala Asn Pro Glu Asn Ser Glu
500 505 510
Val Met Lys Pro Tyr Ser Ser Glu Tyr Lys Thr Ser Thr Ile Ala Tyr
5l5 520 525
Lys Met Pro Phe Ala Gln Phe Pro Lys Asp Cys Trp Ile Thr Phe Asp
530 535 540
Val Ala Ile Asp Trp Thr Lys Tyr Gly Lys Glu Ala Asn Thr Ile Leu
545 550 555 560
Lys Pro Gly Lys Leu Asp Val Met Met Thr Tyr Thr Lys Asn Lys Lys
565 570 575
Pro Gln Lys Ala His Ile Val Asn Gln Gln Glu Ile Leu Ile Gly Arg
580 585 590
Asn Asp Asp Asp Gly Tyr Tyr Phe Lys Phe Gly Ile Tyr Arg Val Gly
595 600 605
Asn Ser Thr Val Pro Val Thr Tyr Asn Leu Ser Gly Tyr Ser Glu Thr
610 615 620
Ala Arg
625
<210>3
<211>1881
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>3
atgagtaaag gagaagaact tttcactgga gttgtcccaa ttcttgttga attagatggc 60
gatgttaatg ggcaaaaatt ctctgtcagt ggagtcccaa ttcttgttga attagatggc 120
gatgttaatg ggcaaaaatt ctctgtcagt ggagagctac ctgttccatg gccaacactt 180
gtcactactc tgacttatgg tgttcaatgc ttttcactac ctgttccatg gccaacactt 240
gtcactactt tcgcgtatgg tcttcaatgc tttgagctac ctgttccatg gccaacactt 300
gtcactactt tcgcgtatgg tcttcaatgc tttgagctac ctgttccatg gccaacactt 360
gtcactactt tcgcgtatgg tcttcaatgc tttgagctac ctgttccatg gccaacactt 420
gtcactactt tcgcgtatgg tcttcaatgc tttgtcatgg cagacaaacc aaagaatgga 480
atcaaagtta acttcaaaat tagacacaac attatcatgg cagacaaacc aaagaatgga 540
atcaaagtta acttcaaaat tagacacaac attatcatgg cagacaaacc aaagaatgga 600
atcaaagtta acttcaaaat tagacacaac attaacgaaa agagagatca catgatcctt 660
cttgagtttg taacagctgc tgggattaca catggcatgg atgaactata caaaggtacc 720
tcgagctcga acaacaacaa caataacaat aacaacaacc tcgggatcga gggaaggatt 780
tcagaattcc agcaaaaaaa atccggtaac atcccttacc gggtaaatgt gcaggccgac 840
agtgctaagc agaaggcgat tattgacaac aaatgggtgg cagtaggcat caataaacct 900
tatgcattac aatatgacga taaactgcgc tttaatggaa aaccatccta tcgctttgag 960
cttaaagccg aagacaattc gcttgaaggt tatgctgcag gagaaacaaa gggccgtaca 1020
gaattgtcgt acagctatgc aaccaccaat gattttaaga aatttccccc aagcgtatac 1080
caaaatgcgc aaaagctaaa aaccgtttat cattacggca aagggatttg tgaacagggg 1140
agctcccgca gctatacctt ttcagtgtac ataccctcct ccttccccga caatgcgact 1200
actatttttg cccaatggca tggtgcaccc agcagaacgc ttgtagctac accagaggga 1260
gaaattaaaa cactgagcat agaagagttt ttggccttat acgaccgcat gatcttcaaa 1320
aaaaatatcg cccatgataa agttgaaaaa aaagataagg acggaaaaat tacttatgta 1380
gccggaaagc caaatggctg gaaggtagaa caaggtggtt atcccacgct ggcctttggt 1440
ttttctaaag ggtattttta catcaaggca aactccgacc ggcagtggct taccgacaaa 1500
gccgaccgta acaatgccaa tcccgagaat agtgaagtaa tgaagcccta ttcctcggaa 1560
tacaaaactt caaccattgc ctataaaatg ccctttgccc agttccctaa agattgctgg 1620
attacttttg atgtcgccat agactggacg aaatatggaa aagaggccaa tacaattttg 1680
aaacccggta agctggatgt gatgatgact tataccaaga ataagaaacc acaaaaagcg 1740
catatcgtaa accagcagga aatcctgatc ggacgtaacg atgacgatgg ctattacttc 1800
aaatttggaa tttacagggt cggtaacagc acggtcccgg ttacttataa cctgagcggg 1860
tacagcgaaa ctgccagata g 1881
<210>4
<211>2271
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>4
atgaaaatcg aagaaggtaa actggtaatc tggattaacg gcgataaagg ctataacggt 60
ctcgctgaag tcggtaagaa attcgagaaa gataccggaa ttaaagtcac cgttgagcat 120
ccggataaac tggaagagaa attcccacag gttgcggcaa ctggcgatgg ccctgacatt 180
atcttctggg cacacgaccg ctttggtggc tacgctcaat ctggcctgtt ggctgaaatc 240
accccggaca aagcgttcca ggacaagctg tatccgttta cctgggatgc cgtacgttac 300
aacggcaagc tgattgctta cccgatcgct gttgaagcgt tatcgctgat ttataacaaa 360
gatctgctgc cgaacccgcc aaaaacctgg gaagagatcc cggcgctgga taaagaactg 420
aaagcgaaag gtaagagcgc gctgatgttc aacctgcaag aaccgtactt cacctggccg 480
ctgattgctg ctgacggggg ttatgcgttc aagtatgaaa acggcaagta cgacattaaa 540
gacgtgggcg tggataacgc tggcgcgaaa gcgggtctga ccttcctggt tgacctgatt 600
aaaaacaaac acatgaatgc agacaccgat tactccatcg cagaagctgc ctttaataaa 660
ggcgaaacag cgatgaccat caacggcccg tgggcatggt ccaacatcga caccagcaaa 720
gtgaattatg gtgtaacggt actgccgacc ttcaagggtc aaccatccaa accgttcgtt 780
ggcgtgctga gcgcaggtat taacgccgcc agtccgaaca aagagctggc aaaagagttc 840
ctcgaaaact atctgctgac tgatgaaggt ctggaagcgg ttaataaaga caaaccgctg 900
ggtgccgtag cgctgaagtc ttacgaggaa gagttggcga aagatccacg tattgccgcc 960
actatggaaa acgcccagaa aggtgaaatc atgccgaaca tcccgcagat gtccgctttc 1020
tggtatgccg tgcgtactgc ggtgatcaac gccgccagcg gtcgtcagac tgtcgatgaa 1080
gccctgaaag acgcgcagac taattcgagc tcgaacaaca acaacaataa caataacaac 1140
aacctcggga tcgagggaag gatttcagaa ttcggatccc agcaaaaaaa atccggtaac 1200
atcccttacc gggtaaatgt gcaggccgac agtgctaagc agaaggcgat tattgacaac 1260
aaatgggtgg cagtaggcat caataaacct tatgcattac aatatgacga taaactgcgc 1320
tttaatggaa aaccatccta tcgctttgag cttaaagccg aagacaattc gcttgaaggt 1380
tatgctgcag gagaaacaaa gggccgtaca gaattgtcgt acagctatgc aaccaccaat 1440
gattttaaga aatttccccc aagcgtatac caaaatgcgc aaaagctaaa aaccgtttat 1500
cattacggca aagggatttg tgaacagggg agctcccgca gctatacctt ttcagtgtac 1560
ataccctcct ccttccccga caatgcgact actatttttg cccaatggca tggtgcaccc 1620
agcagaacgc ttgtagctac accagaggga gaaattaaaa cactgagcat agaagagttt 1680
ttggccttat acgaccgcat gatcttcaaa aaaaatatcg cccatgataa agttgaaaaa 1740
aaagataagg acggaaaaat tacttatgta gccggaaagc caaatggctg gaaggtagaa 1800
caaggtggtt atcccacgct ggcctttggt ttttctaaag ggtattttta catcaaggca 1860
aactccgacc ggcagtggct taccgacaaa gccgaccgta acaatgccaa tcccgagaat 1920
agtgaagtaa tgaagcccta ttcctcggaa tacaaaactt caaccattgc ctataaaatg 1980
ccctttgccc agttccctaa agattgctgg attacttttg atgtcgccat agactggacg 2040
aaatatggaa aagaggccaa tacaattttg aaacccggta agctggatgt gatgatgact 2100
tataccaaga ataagaaacc acaaaaagcg catatcgtaa accagcagga aatcctgatc 2160
ggacgtaacg atgacgatgg ctattacttc aaatttggaa tttacagggt cggtaacagc 2220
acggtcccgg ttacttataa cctgagcggg tacagcgaaa ctgccagatg a 2271

Claims (10)

1, heparanase expression carrier is the procaryotic cell expression carrier that is inserted with the encoding gene of the fusion rotein that is made of heparinase and green fluorescent protein in multiple clone site.
2, heparanase expression carrier according to claim 1 is characterized in that: the described procaryotic cell expression carrier that is inserted with the encoding gene of the fusion rotein that is made of heparinase and green fluorescent protein in multiple clone site can be at the expression in escherichia coli foreign gene.
3, heparanase expression carrier according to claim 1 is characterized in that: described intestinal bacteria are bacillus coli DH 5 alpha, e. coli bl21 (DE3), e. coli jm109 or intestinal bacteria TB1.
4, according to claim 1,2 or 3 described heparanase expression carriers, it is characterized in that: the described fusion rotein that is made of heparinase and green fluorescent protein is the gfp fragment that closely is connected with the 1-238 amino acids residue sequence that has sequence 1 in the sequence table at least at the aminoterminal of the amino acid residue sequence of heparinase or carboxyl terminal.
5, heparanase expression carrier according to claim 4 is characterized in that: described heparinase is a Heparinase I, and its amino acid residue sequence is numbered A47479 in the retrieval of GenBank.
6, heparanase expression carrier according to claim 5 is characterized in that: the described fusion rotein that is made of heparinase and green fluorescent protein is the protein with one of following amino acid residue sequences:
1) the SEQ ID № in the sequence table: 2;
2) with SEQ ID № in the sequence table: 2 amino acid residue sequence is through the replacement of one or several amino-acid residue and/or disappearance and/or interpolation and have green fluorescent protein and the protein of heparanase activity.
7, heparanase expression carrier according to claim 6 is characterized in that: the encoding gene of the described fusion rotein that is made of heparinase and green fluorescent protein has one of following nucleotide sequence:
1) SEQ ID № in the sequence table: 3 dna sequence dna;
2) SEQ ID № in the code sequence tabulation: the polynucleotide of 2 protein sequences;
3) under the rigorous condition of height can with SEQ ID № in the sequence table: the nucleotide sequence of the 3 dna sequence dnas hybridization that limit;
4) with SEQ ID №: 3 dna sequence dnas that limit have 90% above homology, and coding identical function protein DNA sequence.
8, heparanase expression carrier according to claim 7 is characterized in that: described heparanase expression carrier is pGFP-hepA; Described pGFP-hepA is that the encoding gene of the fusion rotein that will be made of heparinase and green fluorescent protein inserts the recombinant expression vector that obtains between NdeI in the multiple clone site of pMAL-c2x and HindIII recognition site.
9, a kind of method of expressing heparinase is that arbitrary described heparanase expression carrier in the claim 2 to 8 is imported in the intestinal bacteria, and the bacterial strain that screening is obtained expressing heparinase is cultivated described engineering bacteria, the abduction delivering heparinase as engineering bacteria.
10, method according to claim 9 is characterized in that: described intestinal bacteria are bacillus coli DH 5 alpha, e. coli bl21 (DE3), e. coli jm109 or intestinal bacteria TB1; Described heparanase expression carrier is pGFP-hepA; Described abduction delivering condition in the substratum that contains 0.3-1mM IPTG 10-30 ℃ inducing culture 5-15 hour.
CNB2005100908722A 2005-08-18 2005-08-18 Method of expressing heparinase and its special expression carrier Expired - Fee Related CN100355893C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100908722A CN100355893C (en) 2005-08-18 2005-08-18 Method of expressing heparinase and its special expression carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100908722A CN100355893C (en) 2005-08-18 2005-08-18 Method of expressing heparinase and its special expression carrier

Publications (2)

Publication Number Publication Date
CN1757739A true CN1757739A (en) 2006-04-12
CN100355893C CN100355893C (en) 2007-12-19

Family

ID=36703307

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100908722A Expired - Fee Related CN100355893C (en) 2005-08-18 2005-08-18 Method of expressing heparinase and its special expression carrier

Country Status (1)

Country Link
CN (1) CN100355893C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691613B2 (en) 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
WO2011011906A1 (en) * 2009-07-29 2011-02-03 清华大学 A fusion heparinase, its coding gene and use
CN101608180B (en) * 2009-07-29 2011-08-10 清华大学 Fusion heparinase and coding gene thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7888072B2 (en) 2005-11-03 2011-02-15 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US8198050B2 (en) 2005-11-03 2012-06-12 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691613B2 (en) 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
WO2011011906A1 (en) * 2009-07-29 2011-02-03 清华大学 A fusion heparinase, its coding gene and use
CN101608180B (en) * 2009-07-29 2011-08-10 清华大学 Fusion heparinase and coding gene thereof

Also Published As

Publication number Publication date
CN100355893C (en) 2007-12-19

Similar Documents

Publication Publication Date Title
CN1132845C (en) Improved method for obtaining isulin precursor having correctly-bonded cystine bond
CN101063145A (en) Expression carrier for black porgy antibiotic peptide Hepcidin and expression product and constructing preparation method
CN1757739A (en) Method of expressing heparinase and its special expression carrier
CN1511849A (en) Novel alpha interferon mutant and its preparing process
CN1699424A (en) Heparinase I fusion protein and genes encoding same and expression method thereof
CN1111909A (en) Novel polypeptide and DNA coding for the same
CN1156575C (en) Escherichia coli strain secreting human granulocyte colony stimulating factor (G-CSF)
CN101045933A (en) Cryophilous proteinase gene mcp01 and its prepn process
CN1141387C (en) Novel PPGPP synthetase and expression systems for improved production of protein of interest
CN101062942A (en) Aspergillus fumigatus original active oxygen lethality related protein and its coding gene
CN100347294C (en) Thermostabilized trehasynthetase, coding gene and use thereof
CN101058805A (en) Method of producing mutation procarboxypeptidase B and mutation carboxypeptidase B
CN1234726C (en) Nucleic acid, expression carrier and application of steady wheat high molecular gluten Dtx1, 5 subunit coding gene
CN1280415C (en) Wheat disease-resistant gene Lr-L1 and its use
CN1300320A (en) Assay for the diagnosis of schizophrenia based on a new peptide
CN101041690A (en) Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof
CN1260347C (en) Hydantoin enzyme series and encoded gene and production bacteria thereof
CN1301266C (en) High molecular wheat glutelin subunit, genes encoding same and use thereof
CN1712531A (en) High-molecular glutelin By8 gene of flint wheat and use thereof
CN1814755A (en) High-temperature neutral protease and preparing method
CN1523036A (en) Anti-coagulate protein and its coding gene and high effective expression method
CN1742078A (en) Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
CN100351378C (en) Aldehyde-alcohol dehydrogenase gene
CN101058818A (en) Hydantoinase gene, coded amino acid and application thereof
CN1807639A (en) L-lactate dehydrogenase gene and its coded amino acid sequence and the primer designed in preparation process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071219

Termination date: 20170818

CF01 Termination of patent right due to non-payment of annual fee